132 related articles for article (PubMed ID: 29072257)
1. Therapeutic effects of a taurine-magnesium coordination compound on experimental models of type 2 short QT syndrome.
An MY; Sun K; Li Y; Pan YY; Yin YQ; Kang Y; Sun T; Wu H; Gao WZ; Lou JS
Acta Pharmacol Sin; 2018 Mar; 39(3):382-392. PubMed ID: 29072257
[TBL] [Abstract][Full Text] [Related]
2. [Anti-arrhythmic effects of taurine-magnesium coordination compound on torsades de pointes].
Li Y; Sun K; An MY; Pan YY; Sun T; Yin YQ; Kang Y; Lou JS
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Feb; 34(2):106-110. PubMed ID: 29926671
[TBL] [Abstract][Full Text] [Related]
3. Effects of taurine-magnesium coordination compound on ionic channels in rat ventricular myocytes of arrhythmia induced by ouabain.
Zhao L; Lou J; Wu H; Yin Y; Kang Y
Biol Trace Elem Res; 2012 Jun; 147(1-3):275-84. PubMed ID: 22311082
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of sodium current by taurine magnesium coordination compound prevents cesium chloride-induced arrhythmias.
Yin Y; Wen K; Wu Y; Kang Y; Lou J
Biol Trace Elem Res; 2012 May; 146(2):192-8. PubMed ID: 22057978
[TBL] [Abstract][Full Text] [Related]
5. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
6. Taurine-magnesium coordination compound, a potential anti-arrhythmic complex, improves aconitine-induced arrhythmias through regulation of multiple ion channels.
Lou J; Wu H; Wang L; Zhao L; Li X; Kang Y; Wen K; Yin Y
Toxicol Appl Pharmacol; 2018 Oct; 356():182-190. PubMed ID: 30125596
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic effects of taurine magnesium coordination compound on cardiac sodium channel Nav1.5.
Zhao L; Yang XX; Yin YQ; Wu H; Kang Y; Lou JS
Mol Med Rep; 2017 Oct; 16(4):4259-4264. PubMed ID: 28765943
[TBL] [Abstract][Full Text] [Related]
8. Taurine-magnesium coordination compound attenuates hypoxia/reoxygenation induced ion channel dysfunction in rat ventricular myocytes.
Zhao L; Lou JS; Kang Y
Drug Res (Stuttg); 2013 Apr; 63(4):185-91. PubMed ID: 23487402
[TBL] [Abstract][Full Text] [Related]
9. [Impact of late sodium current inhibition on cardiac electrophysiology parameters and ventricular arrhythmias in isolated Langendorff perfused rabbit hearts with short QT interval].
Huang YW; Chen Y; Wang CY; Wu L
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Nov; 50(11):1087-1093. PubMed ID: 36418277
[No Abstract] [Full Text] [Related]
10. New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts.
Kui P; Orosz S; Takács H; Sarusi A; Csík N; Rárosi F; Csekő C; Varró A; Papp JG; Forster T; Farkas AS; Farkas A
J Pharmacol Toxicol Methods; 2016; 80():26-34. PubMed ID: 27063345
[TBL] [Abstract][Full Text] [Related]
11. Compound ICA-105574 prevents arrhythmias induced by cardiac delayed repolarization.
Meng J; Shi C; Li L; Du Y; Xu Y
Eur J Pharmacol; 2013 Oct; 718(1-3):87-97. PubMed ID: 24041920
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of the β-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels.
Bodi I; Franke G; Pantulu ND; Wu K; Perez-Feliz S; Bode C; Zehender M; zur Hausen A; Brunner M; Odening KE
J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1163-71. PubMed ID: 23718892
[TBL] [Abstract][Full Text] [Related]
13. Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole-Heart Model of Short QT Syndrome.
Frommeyer G; Ellermann C; Dechering DG; Kochhäuser S; Bögeholz N; Güner F; Leitz P; Pott C; Eckardt L
J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1214-1219. PubMed ID: 27283775
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic properties of ivabradine in an experimental model of Short-QT- Syndrome.
Frommeyer G; Weller J; Ellermann C; Kaese S; Kochhäuser S; Lange PS; Dechering DG; Eckardt L
Clin Exp Pharmacol Physiol; 2017 Sep; 44(9):941-945. PubMed ID: 28556923
[TBL] [Abstract][Full Text] [Related]
15. Modeling the effects of amiodarone on short QT syndrome variant 2 in the human ventricles.
Cunjin Luo ; Kuanquan Wang ; Henggui Zhang
Annu Int Conf IEEE Eng Med Biol Soc; 2017 Jul; 2017():4273-4276. PubMed ID: 29060841
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologically induced long QT type 2 can be rescued by activation of IKs with benzodiazepine R-L3 in isolated guinea pig cardiomyocytes.
Nissen JD; Diness JG; Diness TG; Hansen RS; Grunnet M; Jespersen T
J Cardiovasc Pharmacol; 2009 Aug; 54(2):169-77. PubMed ID: 19568177
[TBL] [Abstract][Full Text] [Related]
17. Iloperidone (Fanapt®), a novel atypical antipsychotic, is a potent HERG blocker and delays cardiac ventricular repolarization at clinically relevant concentration.
Vigneault P; Pilote S; Patoine D; Simard C; Drolet B
Pharmacol Res; 2012 Jul; 66(1):60-5. PubMed ID: 22465688
[TBL] [Abstract][Full Text] [Related]
18. Modelling the effects of quinidine, disopyramide, and E-4031 on short QT syndrome variant 3 in the human ventricles.
Luo C; Wang K; Zhang H
Physiol Meas; 2017 Sep; 38(10):1859-1873. PubMed ID: 28812984
[TBL] [Abstract][Full Text] [Related]
19. Barbaloin inhibits ventricular arrhythmias in rabbits by modulating voltage-gated ion channels.
Cao ZZ; Tian YJ; Hao J; Zhang PH; Liu ZP; Jiang WZ; Zeng ML; Zhang PP; Ma JH
Acta Pharmacol Sin; 2018 Mar; 39(3):357-370. PubMed ID: 29072259
[TBL] [Abstract][Full Text] [Related]
20. Effects of pinacidil on guinea-pig isolated perfused heart with particular reference to the proarrhythmic effect.
Padrini R; Bova S; Cargnelli G; Piovan D; Ferrari M
Br J Pharmacol; 1992 Mar; 105(3):715-9. PubMed ID: 1628158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
